trial summary · NCT07719608
A Pivotal Clinical Study to Evaluate the MySalvia System for the Treatment of Resistant Migraine
Randomized, Double-Blind, Controlled Pivotal Trial of the MySalvia System for the Treatment of Resistant Migraine
Trial record from the TrialBase DB dataset, status RECRUITING, condition Resistant Migraine, sponsored by Salvia BioElectronics. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
The purpose of this pivotal clinical study is to evaluate the safety and effectiveness of the MySalvia System, a minimally invasive implantable neuromodulation therapy, for the preventive treatment of adults with resistant migraine.
Source record: https://clinicaltrials.gov/study/NCT07719608
Facts
| registry id | NCT07719608 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | not reported |
| study type | INTERVENTIONAL |
| lead condition | Resistant Migraine |
| sponsor | Salvia BioElectronics |
| sponsor class | INDUSTRY |
| enrollment | 150 |
| start date | 2026-12-01 |
| primary completion | 2028-10-01 |
| completion | 2031-05-01 |
| results posted | not reported |
Conditions
- Resistant Migraine
- Chronic Migraine Headache
- Headache (Migraine)
- Headache, Cluster
Interventions
- Neurostimulator
Countries
- United States
Intervention types: DEVICE
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.